Replies to post #2265 on BrainStorm Cell Therapeutics Inc (BCLI)

[early_retirement2]

unfortunately, it's been pretty silent from the company since the Phase 2 results. I go to their website at least once a week hoping to see something new but nothing yet. management said they would be meeting with patients to go over results and meet with FDA. they plan to move forward with phase 3 study but there hasn't been anything released to the public with a plan moving forward.

I speculate when they have phase 3 plans, they might comment on the early access program. I'm surprised at how silent it's been. phase 2 results were great but I think a lot investors might be confused with the results or just holding to invest.

[early_retirement2]

correction - they haven't been totally silent. they released 2nd and 3rd quarter results, presented at a couple conferences, and they were granted a patent for their stem cell technology.

the patent is by far the most important news. as for early access program and phase 3 plans, it's been silent.